rs112039037
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_025074.7(FRAS1):āc.11306A>Gā(p.Asn3769Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00013 in 1,604,200 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_025074.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000506 AC: 77AN: 152142Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000134 AC: 32AN: 238576Hom.: 0 AF XY: 0.0000696 AC XY: 9AN XY: 129338
GnomAD4 exome AF: 0.0000902 AC: 131AN: 1451940Hom.: 0 Cov.: 32 AF XY: 0.0000845 AC XY: 61AN XY: 721918
GnomAD4 genome AF: 0.000512 AC: 78AN: 152260Hom.: 0 Cov.: 31 AF XY: 0.000510 AC XY: 38AN XY: 74458
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:2
- -
This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 3769 of the FRAS1 protein (p.Asn3769Ser). This variant is present in population databases (rs112039037, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with FRAS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 283916). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
- -
- -
Fraser syndrome 1 Uncertain:1Benign:1
- -
The missense c.11306A>G (p.Asn3769Ser) variant in FRAS1 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Asn3769Ser variant is reported with an allele frequency of 0.01% in the gnomAD exomes database. This variant has been reported to the ClinVar database as Likely Benign / Uncertain Significance (multiple submissions). The amino acid change p.Asn3769Ser in FRAS1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The amino acid Asn at position 3769 is changed to a Ser changing protein sequence and it might alter its composition and physico-chemical properties. For these reasons, this variant has been classified as a Variant of Uncertain Significance (VUS). -
FRAS1-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at